Chinese contract research organization (CRO) Biocytogen has raised a RMB543 million ($78 million) Series D round led by China Life Insurance and SDIC Venture Capital, a VC arm of the State Development & Investment Corporation (SDIC).
Existing investors CMB International – an investment arm of China Merchants Bank – Materia Medica Capital, and 3E Bioventures also participated in the funding round, according to a release. All three...
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
Spinny has followed fellow Indian automotive marketplace Droom into unicorn territory, closing a $283 million Series F round at a valuation of $1.8 billion.
Indian agriculture industry platform provider AgroStar has raised a $70 million Series D round led by Evolvence Capital, Schroders Capital, Hero Enterprise, and CDC Group.